Ltd. officially announced the launch of "Sanyou Super Trillion Common Light Chain Antibody Discovery Platform" (the "platform"). As one of the nine trillion antibody discovery platforms of Sanyou ...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced United States Patent and Trademark Office (USPTO) patent grant for independently developed RenLite fully human common light chain mouse ...

The anti-HER2 biparatopic antibody (bpAb) KJ-015 was rationally designed at Shanghai Bao Pharmaceuticals Co. Ltd. by leveraging published antibody-antigen structures to share common light chain with ...

BEIJING, June 21, 2024 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced United States Patent and Trademark Office (USPTO) patent grant for ...

Ltd. ("Biocytogen", HKEX: 02315) announced United States Patent and Trademark Office (USPTO) patent grant for independently developed RenLite ® fully human common light chain mouse platform.

Although both these forms of systemic amyloidosis are common, ATTRwt amyloidosis is more prevalent. Fibrillogenesis in immunoglobulin light chain (AL) amyloidosis is initiated from a small B-cell ...